BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kala S, Watson B, Zhang JG, Papp E, Guzman Lenis M, Dennehy M, Cameron DW, Harrigan PR, Serghides L. Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens. Antiviral Res 2018;159:45-54. [PMID: 30236532 DOI: 10.1016/j.antiviral.2018.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Kala S, Dunk C, Acosta S, Serghides L. Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies. Hum Reprod 2020;35:1781-96. [PMID: 32712670 DOI: 10.1093/humrep/deaa151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ikumi NM, Anumba D, Matjila M. Pharmacokinetics and placental transfer of dolutegravir in pregnancy. J Antimicrob Chemother 2021:dkab365. [PMID: 34618029 DOI: 10.1093/jac/dkab365] [Reference Citation Analysis]
3 Gilmore JC, Zhang G, Cameron DW, Serghides L, Bendayan R. Impact of in-utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain. AIDS 2021;35:2249-58. [PMID: 34175869 DOI: 10.1097/QAD.0000000000003009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Gilmore JC, Hoque MT, Dai W, Mohan H, Dunk C, Serghides L, Bendayan R. Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta. EBioMedicine 2021;75:103771. [PMID: 34954655 DOI: 10.1016/j.ebiom.2021.103771] [Reference Citation Analysis]
5 Sarkar A, Balogun K, Guzman Lenis MS, Acosta S, Mount HT, Serghides L. In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PLoS One 2020;15:e0242513. [PMID: 33211746 DOI: 10.1371/journal.pone.0242513] [Reference Citation Analysis]
6 Mohan H, Lenis MG, Laurette EY, Tejada O, Sanghvi T, Leung KY, Cahill LS, Sled JG, Delgado-Olguín P, Greene NDE, Copp AJ, Serghides L. Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels. EBioMedicine 2021;63:103167. [PMID: 33341441 DOI: 10.1016/j.ebiom.2020.103167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Balogun K, Serghides L. Comparison of the Effects of Three Dual-Nucleos(t)ide Reverse Transcriptase Inhibitor Backbones on Placenta Mitochondria Toxicity and Oxidative Stress Using a Mouse Pregnancy Model. Pharmaceutics 2022;14:1063. [DOI: 10.3390/pharmaceutics14051063] [Reference Citation Analysis]